Orsini's Exclusive Partnership with Ionis for Groundbreaking DAWNZERA Medication Orsini has been named the exclusive specialty pharmacy partner for Ionis Pharmaceuticals' new drug, DAWNZERA, aimed at treating hereditary angioedema.

Orsini's Exclusive Partnership with Ionis for Groundbreaking DAWNZERA Medication #United_States #Elk_Grove_Village #Ionis_Pharmaceuticals #Orsini_Pharmacy #DAWNZERA

Orsini Partners with PTC Therapeutics to Enhance Care for PKU Patients with SEPHIENCE Orsini, recognized for its dedication to rare disease management, teams up with PTC Therapeutics to support the distribution of SEPHIENCE, a crucial PKU therapy.

Orsini Partners with PTC Therapeutics to Enhance Care for PKU Patients with SEPHIENCE #United_States #Elk_Grove_Village #PTC_Therapeutics #Sephience #Orsini_Pharmacy